Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Cracking Addiction

How Australia's Free Naloxone Program Saves 3 Lives EVERY DAY!

30 Apr 2025

Description

How Australia's Free Naloxone Program Saves 3 Lives EVERY DAY!Australia’s Naloxone Program: Saving Lives, Closing Gaps, and Fighting Opioid Overdose Deaths Addiction Specialist Dr. Ferghal Armstrong dives into the life-saving power of naloxone (Narcan), reversing drug overdoses from fentanyl and painkillers, saving 3 lives daily. Learn how it works as a “blocker” to restore breathing in minutes, plus life-saving techniques from paramedic school and first responder OD training. Shocking gaps persist: Victoria Police can’t carry naloxone, 40% of pharmacies don’t stock it, and stigma endangers families. Uncover overdose EMT insights, policy failures, and reforms needed to combat drug OD as synthetic opioids hit Australia. Chapters00:00:00 Naloxone Saves Lives: Introduction and Key Facts00:00:39 How Naloxone Works: Mechanism and Safety00:01:15 Forms of Naloxone and Accessibility for the Public00:02:10 Evidence Supporting Community Naloxone Programs00:02:57 Successes and Gaps in Australia’s Take Home Naloxone Program00:03:56 Emerging Threats: Synthetic Opioids and Urgency of Intervention00:04:44 Victoria’s Policy Disconnect: Police and Naloxone Access00:05:19 Legal Barriers and Double Standards in Overdose Response00:06:12 Litigation Fears and Naloxone Supply Pressures00:06:54 Misconceptions about Overdose Risk: Prescription Opioids00:07:39 The Need for Culture Change: Normalizing Naloxone Access00:08:20 Solutions and Recommendations: Closing the Gaps00:09:17 Final Thoughts: Lives Saved with Better Policy#overdoseprevention #FentanylOverdose #HarmReduction

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.